共被期刊论文引用了3次
您的检索式：您选中1篇文献正在查看引证文献汇总
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antioxidant therapy in the management of acute,chronic and post-ERCP pancreatitis:A systematic review显示文摘We systematically reviewed the clinical trials which recruited antioxidants in the therapy of pancreatitis and evaluated whether antioxidants improve the outcome of patients with pancreatitis.Electronic bibliographic databases were searched for any studies which investigated the use of antioxidants in the management of acute pancreatitis(AP)or chronic pancreatitis(CP)and in the prevention of post-endoscopic retrograde cholangio-pancreatography(post-ERCP)pancreatitis(PEP)up to February 2009.Twenty-two randomized,placebo-controlled,clinical trials met our criteria and were included in the review.Except for a cocktail of antioxidants which showed improvement in outcomes in three different clinical trials,the results of the administration of other antioxidants in both AP and CP clinical trials were incongruent and heterogeneous.Furthermore,antioxidant therapy including allopurinol and N-acetylcysteine failed to prevent the onset of PEP in almost all trials.In conclusion,the present data do not support a benefit of antioxidant therapy alone or in combination with conventional therapy in the management of AP,CP or PEP.Further double blind,randomized,placebo-controlled clinical trials with large sample size need to be conducted. | Seyed Sajad Mohseni Salehi Monfared Hamed Vahidi Amir Hossein Abdolghaffari Shekoufeh Nikfar Mohammad Abdollahi | 2009 | World Journal of Gastroenterology2009，15，36： | 10 |
| 2 | 1型糖尿病治疗方法的回顾与展望显示文摘1型糖尿病是由包括病毒感染、药物接触及自身免疫在内的各种原因导致的胰岛β细胞凋亡所引起的,主要表现为由血清中胰岛素的绝对缺乏引起的高血糖。在过去数十年中,外源补充胰岛素一直是1型糖尿病的最主要治疗方法。随着人们对1型糖尿病机制的深入了解及生命科学相关技术的发展,科研工作者及临床医生开始探索治疗1型糖尿病的新方法,其中包括将分泌胰岛素的外源胰岛或干细胞移植入体内。或将胰岛素基因直接导入体内,合成并分泌体内缺乏的胰岛素等。本文对胰岛移植、干细胞和基因疗法用于治疗1型糖尿病的主要方式做一简要回顾与综述,并重点讨论近年来的研究进展及其临床应用的可行性。 | 迟毓婧 李晶 管又飞 杨吉春 | 2010 | 生理科学进展2010，41，1： | 8 |
您所在的机构暂未开通此部分的功能，请联系管理员